You are here

News

04/12/2017

Duke University is the first academic center in the west to register a Phase 1 trial testing MSC infusions as therapy for autism. The MSC product will be isolated from umbilical cord tissue by enzymatic digestion, expanded in culture, and cryopreserved.

Read more...
03/27/2017

Registered in February 2017, this trial is a phase 1/2 study that compares bone marrow MSC versus umbilical cord tissue MSC for the treatment of chronic inflammation due to metabolic syndrome.

Read more...
03/07/2017

Our team checked each of the 209 entries in ClinicalTrials.gov that are supposedly open cord blood trials, and found that only 118 of these trials are conducting cell therapy with cord blood. This analysis took weeks of effort, but in the end revealed that for the exact phrase “cord blood”, only 56% of open trials found by keyword hits are active cell therapy trials.

Read more...